Guided Therapeutics (OTCMKTS:GTHP) Releases Earnings Results

Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) released its earnings results on Monday. The company reported ($0.01) earnings per share for the quarter, Zacks reports.

Guided Therapeutics Stock Down 8.3%

Shares of GTHP stock traded down $0.01 during trading hours on Monday, hitting $0.11. 3,200 shares of the company’s stock traded hands, compared to its average volume of 27,412. The stock’s fifty day simple moving average is $0.19 and its two-hundred day simple moving average is $0.25. Guided Therapeutics has a 12-month low of $0.10 and a 12-month high of $0.54. The stock has a market cap of $10.80 million, a price-to-earnings ratio of -2.75 and a beta of 0.78.

Guided Therapeutics Company Profile

(Get Free Report)

Guided Therapeutics is a medical technology company focused on developing tools for the detection of cervical disease. Its principal product is the LuViva Advanced Cervical Scan, a non-invasive device designed to assess cervical tissue for signs associated with precancerous changes and cancer. LuViva uses optical technologies to examine tissue and provide information that can support cervical disease evaluation. The company’s work centers on offering an alternative to diagnostic approaches that rely on collecting and analyzing tissue samples.

Read More

Earnings History for Guided Therapeutics (OTCMKTS:GTHP)

Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.